Circulating Neuroendocrine Transcripts and Gene Cluster Analysis Predict the Efficacy of PRRT

被引：0

作者：

Bodei, L. ^{[1
]}

Kidd, M. ^{[2
]}

Singh, A. ^{[3
]}

Severi, S. ^{[4
]}

Drozdov, I ^{[5
]}

Nicolini, S. ^{[4
]}

Baum, R. ^{[3
]}

Paganelli, G. ^{[4
]}

Kwekkeboom, D. ^{[6
]}

Krenning, E. ^{[6
]}

Modlin, I. M. ^{[7
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Wren Labs, Branford, CT USA

[3] THERANOST Ctr Mol Radiotherapy & Imaging, Zent Klin Bad Berka, Bad Berka, Germany

[4] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Nucl Med & Radiometab Units, Meldola, Italy

[5] Bering Ltd, London, England

[6] Erasmus MC, Nucl Med Dept, Rotterdam, Netherlands

[7] Yale Sch Med, New Haven, CT USA

来源：

NEUROENDOCRINOLOGY | 2017年 / 105卷

关键词：

prrt; efficacy;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：240 / 240

页数：1

共 50 条

[1] Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
L. Bodei
M. Kidd
I. M. Modlin
S. Severi
I. Drozdov
S. Nicolini
D. J. Kwekkeboom
E. P. Krenning
R. P. Baum
G. Paganelli
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 839 - 851
[2] Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
Bodei, L.
Kidd, M.
Modlin, I. M.
Severi, S.
Drozdov, I.
Nicolini, S.
Kwekkeboom, D. J.
Krenning, E. P.
Baum, R. P.
Paganelli, G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (05) : 839 - 851
[3] Circulating Neuroendocrine Tumor Gene Expression for Monitoring Peptide Receptor Radionuclide (PRRT) Efficacy
Bodei, L.
Kidd, M.
Van der Zwan, W.
Singh, A.
Severi, S.
Drozdov, I
Cwikla, J.
Kolasinska-Cwikla, A.
Baum, R. P.
Paganelli, G.
Krenning, E.
Modlin, I
NEUROENDOCRINOLOGY, 2019, 108 : 113 - 113
[4] Measurement of Blood Gene Transcripts Defines PRRT Therapeutic Efficacy
Bodei, L.
Paganelli, G.
Kidd, M.
Severi, S.
Lepensky, C.
Alaimo, D.
Callahan, S.
Drozdov, I
Kwekkeboom, D.
Krenning, E.
Baum, R.
Modlin, I
NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 106 - 106
[5] PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
Bodei, Lisa
Kidd, Mark S.
Singh, Aviral
van der Zwan, Wouter A.
Severi, Stefano
Drozdov, Ignat A.
Malczewska, Anna
Baum, Richard P.
Kwekkeboom, Dik J.
Paganelli, Giovanni
Krenning, Eric P.
Modlin, Irvin M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 895 - 906
[6] PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
Lisa Bodei
Mark S. Kidd
Aviral Singh
Wouter A. van der Zwan
Stefano Severi
Ignat A. Drozdov
Anna Malczewska
Richard P. Baum
Dik J. Kwekkeboom
Giovanni Paganelli
Eric P. Krenning
Irvin M. Modlin
European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 895 - 906
[7] PRRT Neuroendocrine Tumor Response Assessment Using Circulating Transcript Analysis: The NETest
Bodei, L.
Kidd, M.
Singh, A.
van der Zwan, V
Seven, S.
Drozdov, I
Malczewska, A.
Baum, R. P.
Kwekkeboom, D.
Paganelli, G.
Krenning, E.
Modlin, I
NEUROENDOCRINOLOGY, 2020, 110 : 134 - 134
[8] Intratumoral serotonin might decrease the efficacy of PRRT in ileal neuroendocrine tumors
Prasad, V
Kloeppel, G.
Lupp, A.
Wirtz, R.
Kaemmerer, D.
JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 193 - 193
[9] Efficacy of PRRT in Metastatic Neuroendocrine Tumors; A Retrospective Large Single Institutional Study
Jan, H.
Wyld, D.
Burge, M.
NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 137 - 137
[10] Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
Scalorbi, F.
Argiroffi, G.
Baccini, M.
Gherardini, L.
Fuoco, V
Prinzi, N.
Pusceddu, S.
Garanzini, E. M.
Centonze, G.
Kirienko, M.
Seregni, E.
Milione, M.
Maccauro, M.
SCIENTIFIC REPORTS, 2021, 11 (01)

← 1 2 3 4 5 →